Coronary | EPS/Rhythm | Hypertension | Heart Failure | Stroke | Valvular | MVP | Pericardial | Atrial Fib | Congenital | Nutrition | Echocardiography | Nuclear Medicine |Testing | Stents | Acute Coronary Syndromes
Physicians | Offices | Consultation | Pacer Clinic | Chicago | Hinsdale | Lagrange | Oaklawn | Site Info
Vascular ds | Claudication | Do You Have Leg Pain?| Aorta | Aneurysm | Carotid | Renovascular | Subclavian
Women's Health Concerns | Women's Cardiac Risk | Pregnancy and Heart Disease | 'The Heart Truth' | WSC
Cholesterol Management
See a Slide Presentation on Lipid Lowering Therapy
UPDATE Lipid lowering therapy reduces the risk of stroke. Researchers recently published a study showing the beneficial effects of cholesterol reduction on stroke (White et al, New England J Med 2000;343:317). Compared to placebo, Pravastatin (Pravachol) was associated with a 23% reduction in non-bleeding stroke (4.4 vs 3.4%). There was no significant change in the incidence of bleeding (hemorrhagic) stroke between the 2 groups. Read about other reasons it is important to lower your cholesterol.
There is now abundant information to support the practice that aggressive risk factor modification and lowering of serum cholesterol is not only beneficial for 'secondary' prevention in patients with known atherosclerosis (coronary artery disease, stroke, claudication, peripheral vascular disease) but that achieving optimal cholesterol levels is also quite important for 'primary' prevention in patients without documented atherosclerosis particularly for those who have risk factors for vascular disease (high blood pressure, smoking, diabetes, family history of premature coronary artery disease).
It is estimated that there are 5-6 million Americans with coronary heart disease who should be treated with cholesterol lowering medications. But, only about one-third receive such treatment and even fewer are treated to the appropriate target LDL level. Every 10% reduction in cholesterol translates into a 12-16% decrease in mortality for patients with coronary artery disease.
|
|
|
<100 |
Optimal |
|
|
|
|
|
|
|
|
|
Regardless
of whether medication is needed to control your cholesterol, proper dietary
modification is important. Most foods available in the United States now come
with a label attached to the box or package detailing their fat and calorie
content. Read more about Understanding Food Labels,
Fat Content, and the Mediterranean Diet.
Accordingly, the
National Cholesterol Education Program has set the following parameters
for the drug treatment of high cholesterol:
|
PATIENT CATEGORY |
|
|
|
PRIMARY PREVENTION- No Heart Disease |
||
|
< 2 Risk Factors |
|
|
|
2 or More Risk Factors |
|
|
|
|
||
|
SECONDARY PREVENTION |
||
|
Known Coronary Disease |
|
|
These
recommendations should be individualized, particularly for younger patients
and pre-menopausal women. Diabetic patients are generally treated very aggressively.
Please consult your doctor for further recommendations.
We
can help you with cholesterol measurement and appropriate diet management and
drug therapy. Our Oak
Lawn , LaGrange,
and Hinsdale
offices are equipped with cholesterol measuring machines that are capable of
determining a complete lipid profile in a matter of minutes from a simple finger
stick while you wait. The test is best done after a 4-8 hour fast. (We can also
perform Protime measurements for Coumadin patients in the office from a similar
finger stick)
External Links:
http://westsubcardiology.com | ©West
Suburban Cardiologists, Ltd 1999-2004 | All Rights Reserved
About This Site | Disclaimer | Privacy
Statement | Web site by: Thomas Levin,
MD